Tom Flatt
(703) 838-0033 ext. 328

14 March 2013

Exact Sciences Receives 2013 AMGA Distinguished Corporate Partner Award

ORLANDO, FL-The American Medical Group Association (AMGA) announced today that it will present the AMGA Distinguished Corporate Partner Award on March 15 to Exact Sciences at its 2013 Annual Conference, March 14-16 at the Hilton Bonnet Creek Resort in Orlando. The AMGA Distinguished Corporate Partner Award is presented annually to a non-medical group organization for providing excellent service and value to medical groups and their patients.

The AMGA Distinguished Corporate Partner Award is presented annually to an industry partner organization for providing excellent service and value to medical groups and their patients.  This year we honor an organization that has been an avid supporter of AMGA and its members, and this award demonstrates our appreciation for their continued support.

Exact Sciences is an Executive Corporate Partner of AMGA. In addition they have been active supporters of AMGA's educational activities, including the 2012 and 2013 Annual Conferences. This award represents AMGA's appreciation of Exact Science's continued support and the valuable resources it offers AMGA members. Accepting the award for Exact Scienes is Kevin T. Conroy, president & chief executive officer.

"The American Medical Group Association applauds Exact Sciences for its unwavering dedication to healthcare professionals and the practice of quality medicine in this country," said Donald W. Fisher, Ph.D., CAE, AMGA's President and Chief Executive Officer.  "Their support has enabled us to provide invaluable resources and educational and networking forums for healthcare professionals. We look forward to their future contributions to the work of AMGA members as they quest to improve the delivery of quality patient care."

For more information on the AMGA Distinguished Corporate Partner Award, visit

About Exact Sciences
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of both colorectal cancer and pre-cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

About AMGA
The American Medical Group Association represents some of the nation's largest, most prestigious medical practices, independent practice associations, accountable care organizations, and integrated healthcare delivery systems. AMGA's mission is to support its members in enhancing population health and care for patients through integrated systems of care. More than 130,000 physicians practice in AMGA member organizations, providing healthcare services for 120 million patients (approximately one in three Americans). Headquartered in Alexandria, Virginia, AMGA is the strategic partner for these organizations, providing a comprehensive package of benefits, including political advocacy, educational and networking programs, publications, benchmarking data services, and financial and operations assistance.